Krystal Biotech Inc (KRYS)
182.47
+4.37
(+2.45%)
USD |
NASDAQ |
Nov 21, 16:00
182.47
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Market Cap: 5.248B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.122B |
| November 19, 2024 | 5.115B |
| November 18, 2024 | 5.051B |
| November 15, 2024 | 4.911B |
| November 14, 2024 | 5.102B |
| November 13, 2024 | 5.298B |
| November 12, 2024 | 5.385B |
| November 11, 2024 | 5.633B |
| November 08, 2024 | 5.741B |
| November 07, 2024 | 5.334B |
| November 06, 2024 | 5.266B |
| November 05, 2024 | 5.016B |
| November 04, 2024 | 4.914B |
| November 01, 2024 | 5.073B |
| October 31, 2024 | 4.962B |
| October 30, 2024 | 5.048B |
| October 29, 2024 | 5.068B |
| October 28, 2024 | 5.087B |
| October 25, 2024 | 5.047B |
| October 24, 2024 | 5.032B |
| October 23, 2024 | 4.968B |
| October 22, 2024 | 5.038B |
| October 21, 2024 | 5.147B |
| October 18, 2024 | 5.153B |
| October 17, 2024 | 5.085B |
| Date | Value |
|---|---|
| October 16, 2024 | 5.112B |
| October 15, 2024 | 5.132B |
| October 14, 2024 | 5.164B |
| October 11, 2024 | 5.139B |
| October 10, 2024 | 4.979B |
| October 09, 2024 | 4.946B |
| October 08, 2024 | 5.028B |
| October 07, 2024 | 5.032B |
| October 04, 2024 | 5.093B |
| October 03, 2024 | 5.059B |
| October 02, 2024 | 5.101B |
| October 01, 2024 | 5.219B |
| September 30, 2024 | 5.235B |
| September 27, 2024 | 5.089B |
| September 26, 2024 | 5.126B |
| September 25, 2024 | 5.158B |
| September 24, 2024 | 5.156B |
| September 23, 2024 | 5.177B |
| September 20, 2024 | 5.291B |
| September 19, 2024 | 5.300B |
| September 18, 2024 | 5.250B |
| September 17, 2024 | 5.437B |
| September 16, 2024 | 5.581B |
| September 13, 2024 | 5.791B |
| September 12, 2024 | 5.621B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
607.87M
Minimum
Mar 18 2020
6.134B
Maximum
Jul 26 2024
2.268B
Average
1.763B
Median
Market Cap Benchmarks
| Bioventus Inc | 753.04M |
| ADMA Biologics Inc | 5.034B |
| Alnylam Pharmaceuticals Inc | 31.84B |
| Amicus Therapeutics Inc | 2.834B |
| Rhythm Pharmaceuticals Inc | 3.625B |
Market Cap Related Metrics
| PE Ratio | 102.51 |
| PS Ratio | 22.23 |
| Price to Book Value | 5.924 |
| Price to Free Cash Flow | 92.46 |
| Price | 182.47 |
| Earnings Yield | 0.98% |
| Operating PE Ratio | 82.65 |
| Normalized PE Ratio | 62.75 |